Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4503
-0.0014 (-0.31%)
Jul 9, 2026, 3:08 PM EDT - Market open
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $48.55 million as of July 9, 2026. Its market cap has increased by 378.26% in one year.
Market Cap
48.55M
Enterprise Value
48.68M
1-Year Change
378.26%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $48.55M, an increase of 40.76%. That is a compound annual growth rate of 20.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 48.55M | -8.10% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 53.46M |
| Instil Bio | 52.56M |
| Mereo BioPharma Group | 50.36M |
| Lantern Pharma | 50.01M |
| Hyperion DeFi | 49.64M |
| Radiopharm Theranostics | 49.16M |
| CervoMed | 48.69M |
| Eloxx Pharmaceuticals | 48.60M |